Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Dimension Inx
AddedFeb 15, 2024
UpdatedJun 18, 2026
Dimension Inx

Dimension Inx

Series A

Dimension Inx: Pioneering the development of regenerative microenvironments.

HQ
Chicago, IL, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Dimension Inx was founded with the core mission of pioneering the development of regenerative microenvironments. The company designs and develops therapeutic products aimed at restoring tissue and organ function. Utilizing advanced biomaterials and a sophisticated manufacturing process, Dimension Inx offers unparalleled design versatility and nuanced microarchitecture that enhances biofunctionality. Their market focus includes medical applications where tissue regeneration and repair are critical.

Notable affiliated people include experts in biomaterials and regenerative medicine, though specific names are not provided. Dimension Inx has achieved significant milestones in the field of regenerative medicine, contributing to advancements in tissue engineering and therapeutic solutions. Their impact is evident in the improved outcomes for patients requiring tissue and organ restoration, positioning them as leaders in the regenerative microenvironment space.

Dimension Inx - Similar Companies

Histogen logo

Histogen

histogen.com

CuraSeal logo

CuraSeal

Innervace logo

Innervace

innervace.com

Endogena Therapeutics logo

Endogena Therapeutics

TissueForm logo

TissueForm

tissueforminc.com

CarthroniX logo

CarthroniX

carthronix.com

RegenX logo

RegenX

Eqalix logo

Eqalix

eqalix.com

Tissue Regeneration logo

Tissue Regeneration

Regenemed logo

Regenemed

regenemed.com

InGeneron logo

InGeneron

ingeneron.com

GeniPhys logo

GeniPhys

geniphys.com

Molecular Matrix logo

Molecular Matrix

Spheringenics logo

Spheringenics

Amphix Bio logo

Amphix Bio

amphixbio.com

Dimension Inx - Quick Facts

Who are Dimension Inx's competitors?

Companies similar to Dimension Inx include Histogen, CuraSeal, Innervace and Endogena Therapeutics.

When was Dimension Inx founded?

Dimension Inx was founded in 2017.

Where is Dimension Inx's headquarters located?

Dimension Inx's headquarters is located in Chicago, IL, US.

When was Dimension Inx's last funding round?

Dimension Inx's most recent funding round was for $12M (USD) in February 2023.

How much has Dimension Inx raised to-date?

As of Feb 1, 2023, Dimension Inx has raised a total of $17.7M (USD).

How many employees does Dimension Inx have?

Dimension Inx has 37 employees as of Feb 5, 2024.

Dimension Inx - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Government
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 1 more industry code
NAICS
  • 623000Nursing and Residential Care Facilities